Literature DB >> 9374382

High-resolution HLA-DRB1 and DQB1 genotyping in Japanese patients with testicular germ cell carcinoma.

E Ozdemir1, Y Kakehi, M Mishina, O Ogawa, Y Okada, D Ozdemir, O Yoshida.   

Abstract

We report for the first time the frequency distributions of HLA-DRB1 and -DQB1 genes in 55 patients with testicular germ cell carcinoma (TGC) using the modified PCR-RFLP method and compare the results with those for 1216 healthy Japanese control subjects. The modified PCR-RFLP method produced accurate, reproducible cleavage patterns that are easily discriminated. HLA-DRB1*0410 was the susceptibility allele (RR = 3.26, P = 0.006) and DQB1*0602 appears to be a candidate protective allele (RR = 0.26, P = 0.02) for TGC in the Japanese. None of the HLA-DRB1 and -DQB1 alleles showed a specific tendency for histological type or clinical stage of the tumours. Previous studies based on serotyping methods failed to show these allelic associations. High-resolution genotyping is essential because the peptide-binding domain of MHC class II molecules is determined more precisely by their genotypes than by their serotypes. In addition, inherent technical difficulties and typing errors of up to 25% make serotyping inefficient. Our results suggest that high-resolution genotyping is a useful genetic marker to determine risk for TGC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374382      PMCID: PMC2228160          DOI: 10.1038/bjc.1997.559

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  HLA antigens and cervical carcinoma.

Authors:  S S Glew; P L Stern; J A Davidson; P A Dyer
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

2.  Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.

Authors:  J M Tiercy; C Morel; A C Freidel; F Zwahlen; L Gebuhrer; H Bétuel; M Jeannet; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 3.  The epidemiology of testicular cancer.

Authors:  Y D Senturia
Journal:  Br J Urol       Date:  1987-10

4.  HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers.

Authors:  N Nomura; M Ota; K Tsuji; H Inoko
Journal:  Tissue Antigens       Date:  1991-08

5.  HLA-DQB1*0301 association with increased cutaneous melanoma risk.

Authors:  J E Lee; J D Reveille; M I Ross; C D Platsoucas
Journal:  Int J Cancer       Date:  1994-11-15       Impact factor: 7.396

6.  HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers.

Authors:  M Ota; T Seki; H Fukushima; K Tsuji; H Inoko
Journal:  Tissue Antigens       Date:  1992-04

7.  The significant effect of HLA-DRB1 matching on long-term kidney graft outcome.

Authors:  Y Ichikawa; M Hashimoto; M Nojima; M Sata; N Fujimoto; M Kyo; M Ishibashi; S Ohshima; H Amemiya; T Fukunishi
Journal:  Transplantation       Date:  1993-12       Impact factor: 4.939

8.  Father-son testicular cancer.

Authors:  K Yoshimura; K Nishimura; S Miyoshi; S Mizutani; T Mise; K Iwasa
Journal:  Urol Int       Date:  1993       Impact factor: 2.089

9.  Regional loss of chromosome 6 in two urological malignancies.

Authors:  D B Rukstalis; G J Bubley; J P Donahue; J P Richie; J G Seidman; W C DeWolf
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

10.  Human-tumor-derived cell lines contain common and different transforming genes.

Authors:  M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

View more
  3 in total

1.  Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: a meta-analysis.

Authors:  Yong-Ning Xin; Zhong-Hua Lin; Xiang-Jun Jiang; Shu-Hui Zhan; Quan-Jiang Dong; Qing Wang; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

3.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.